2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Mabscale, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man Pertuzumab, Perjeta® - Healthy Men | Phase 1 | Unknown | Mabscale, LLC | 114 | 2023-07-20 | 2024-08-16 |
| Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis Rituximab, MabThera® - Rheumatoid Arthritis | Phase 1 | Unknown | Mabscale, LLC | 208 | 2023-06-14 | 2024-09-19 |
Rituximab (1) · pertuzumab (1)
Russia (2)